Video: Genmab CEO Talks About The Commercial Potential And Partnering Success Of Antibody Therapies
Genmab’s Jan van de Winkel talks to Sukaina Virji about the excitement surrounding its multiple myeloma drug Darzalex (daratumumab), the potential of multiple sclerosis candidate ofatumumab, and how he’ll always be a scientist at heart.